Skip to content

Newsroom

type
year
Illustration image.png

Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024

1/15/2025 Stock exchange release
Illustration image.png

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting

1/15/2025 Stock exchange release
Illustration image.png

79,345 Orion Corporation A shares converted into B shares

1/13/2025 Stock exchange release
Illustration image.png

Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide

1/7/2025 Press release
Illustration image.png

Orion and Marinus terminate agreement for ganaxolone in Europe

12/30/2024 Press release
Illustration image.png

CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

12/19/2024 Stock exchange release
Illustration image.png

Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics

12/18/2024 Press release
orionfi_nuoretkohderyhmana_paakuva1_1500x844.jpg

Pathways to the pharmaceutical industry – This is how Orion encourages young people to find their place

12/13/2024 We are Orion
Illustration image.png

Penalty payment to a member of Orion’s Board of Directors for delay in notifying managers’ transaction

12/12/2024 Stock exchange release
orion_huoltovarmuus_paakuva_1500x844.jpg

Orion’s Nordic pharmaceutical production means security for all of Europe

12/2/2024 Orion and Society
orion_ajatusjohtaja_parkinsons_paakuva_1500x844.jpg

More than just tremors – What we should understand about Parkinson’s disease

11/27/2024 Your Health
Illustration image.png

142,701 Orion Corporation A shares converted into B shares

11/27/2024 Stock exchange release
Illustration image.png

Orion Research Foundation grants EUR 1,109,000 for research in 2025

11/22/2024 Press release
orionfi_immuno-onkologia_paakuva_1500x844.jpg

Can we treat cancer by activating the body’s own defence system?

11/21/2024 Science and Partnering
Illustration image.png

Orion and Alligator Bioscience amend their agreement concerning two bispecific antibodies

11/19/2024 Press release
orionfi_menopaussi_tyopaikalla_paakuva_1500x844.jpg

Shattering the silence: menopause awareness as key to more inclusive work environments

11/12/2024 Orion and Society
orionfi_potilastarina_keuhkoahtauma_paakuva_1500x844.jpg

Päivi Kuoppamäki was diagnosed with COPD at the age of 40: “I avoid situations where I might start laughing”

11/4/2024 Your Health